A practical model for early identification of response with methotrexate for moderate to severe psoriasis - 09/05/15
Kenneth Gordon, Northwestern University, Feinberg School of Medicine, Evanston, IL, United States; Murali Sundaram, AbbVie Inc, North Chicago, IL, United States; Srikesh Arunajadai, Analysis Group, Inc, Boston, MA, United States; Meng Xie, Analysis Group, Inc, Boston, MA, United States; James Signorovitch, Analysis Group, Inc, Boston, MA, United States; Keith Betts, Analysis Group, Inc, Boston, MA, United States; Martin Okun, AbbVie Inc, North Chicago, IL, United States
Le texte complet de cet article est disponible en PDF. Design, study conduct, and financial support for the study were provided by AbbVie; AbbVie participated in the interpretation of data, review, and approval of the abstract. |
Vol 72 - N° 5S1
P. AB222 - mai 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?